Georgia Bio President Charles Craig Steps Down As Leader
Friday, November 9, 2012
Posted by: Angela King
Atlanta, GA (November 9, 2012) – Georgia Bio announced today that President Charles Craig is stepping down at the end of 2012 after eight years as the leader of the life sciences industry association.
“It has been an honor to help establish Georgia Bio as one of the leading state biotech associations in the nation and the primary advocate for the life sciences industry in Georgia,” Craig said. “I am nearing completion of a Master of Arts degree in Bioethics from Emory University, and I want to pursue new opportunities that will enable me to apply my bioethics training and professional experience as a biotech industry leader. This is an exciting and challenging time for our industry.”
Under Craig’s leadership, Georgia Bio expanded its membership to include 200 life sciences-related organizations representing tens of thousands of employees. It has become the only industry association in the state with a record of achievement in the areas most critical to Georgia’s future: improving the health of people, animals and the environment; expanding the number of high paying, advanced technology jobs; and enhancing science education in K-12 schools. In 2009, Craig helped to coordinate and welcome the 2009 BIO International Convention to Atlanta, the largest gathering of life sciences industry professionals in the world.
Throughout his time at Georgia Bio, Craig has done advocacy work in Atlanta and Washington DC, providing leadership for life science companies across Georgia. In 2009, he formed the Georgia Biosciences Organization, a 501c6 non-profit sister organization to better educate elected officials about the work of life sciences companies in developing new medicines and devices as well as the significance of the industry to Georgia’s economy. Craig has been named to Georgia Trend's list of 100 most influential Georgians for 5 consecutive years.
Craig joined Georgia Bio as President in January 2005 after serving as author and editor of Ernst & Young’s Global Biotechnology Reports. He was also director of publications for the Washington, DC-based Biotechnology Industry Organization and was an editor and writer for BioWorld Today.
Thomas Callaway, M.D., M.B.A., Georgia Bio Chairman and Founder & President of Life Science Partner, Inc. states: "As Georgia Bio's first president, Charlie leaves a legacy of leadership and vision that helped transform Georgia Bio into one of the nation's leading life science state associations. His critical role in the recruitment of the international conference BIO to Atlanta in 2009 and his leadership in science education, public policy, the fostering of relationships with our research universities and the recruitment of companies like Baxter helped us create a healthier, more integrated life science community in Georgia. We thank him for all his efforts and contributions and wish him well in his future endeavors."
The Georgia Bio Executive Committee has formed a search committee to initiate a search for a President and Chief Executive Officer of Georgia Bio. The goal is to have a successor to Craig by January 1, 2013.
Georgia Bio (www.gabio.org) is the private, non-profit association whose members include pharmaceutical, biotechnology and medical device companies, medical centers, universities and research institutes, government groups and other business organizations involved in the development of life sciences related products and services.